PLA2R及其抗体在膜性肾病的意义

纯纯 张, 利敏 贾

摘要


膜性肾病是中国肾病综合征常见的病理类型之一，也是慢性肾衰竭的常见病因之一。PLA2R 被证实是 MN 的靶抗原，其抗体与膜性肾病的诊断、疾病活动、治疗效果、病情评估等密切相关。论文通过对 PLA2R 及其抗体在 IMN 中作用的最新研究进展进行论述，以总结其在 MN 中的临床意义。

关键词


PLA2R；抗 PLA2R 抗体；膜性肾病

全文:

PDF

参考


Xu Xin, Wang Guobao, Chen Nan, et al. Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China.[J]. Journal of the American Society of Nephrology : JASN,2016,27(12).

Li Jiannan, Cui Zhao, Long Jianyan, et al. Primary glomerular nephropathy among hospitalized patients in a national database in China.[J]. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association,2018,33(12).

曾森,杨倩.原发性肾小球疾病10年病理特征对比研究[J].中国社区医师,2020,36(36):104-105.

Beck L H , Bonegio R G B , Gérard Lambeau, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.[J]. N Engl J Med, 2009, 361(1):11-21.

Jaulmes A, Janvier B,Andreani M, et al. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells[J].Arterioscler Thromb Vasc Biol, 2005,25(6):1161.

Kao CL, Chiou SH, Chen YJ, et al. Increased expression of osteopontin gene in atypical teratoid / rhabdoid tumor of the central nervous system[J]. Modern Pathology,2005,18(6):769-778. [7] Martinez-Pomares L. The mannose receptor[J]. J Leukoc Biolf, 2012,92(6):1177-1186.

Kao Liyo, Lam Vinson, Waldman Meryl, et al. Identification of the immunodominant epitope region in phospholipase A2 receptor- mediating autoantibody binding in idiopathic membranous nephropathy.[J]. Journal of the American Society of Nephrology : JASN,2015,26(2).

Fresquet Maryline, Jowitt Thomas A, Gummadova Jennet, et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy[J]. Journal of the American Society of Nephrology : JASN,2015,26(2).

Seitz-Polski Barbara, Debiec Hanna, Rousseau Alexandra, et al. Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.[J]. Journal of the American Society of Nephrology: JASN,2018,29(2).

Zhang Pingna, Huang Weijun, Zheng Qiyan, et al. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.[J]. Journal of immunology research,2021.

周广宇,孙延霞,周立祥,等.特发性膜性肾病与M型磷脂酶A2受 体基因多态性的相关性[J].中华肾脏病杂志,2013(1):1-5.

Ramachandran Raja, Kumar Vinod, Kumar Ashwani, et al. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians[J]. Narnia,2016,31(9).

Gupta Sanjana, Köttgen Anna, Hoxha Elion, et al. Genetics of membranous nephropathy.[J]. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association,2018,33(9).

Yue Dong, Longxing Cao, Hua Tang, et al. Structure of Human M-type Phospholipase A2 Receptor Revealed by Cryo-Electron Microscopy[J]. Journal of Molecular Biology,2017,429(24).

Li Ting, Wu Qingqing, Yang Xue, et al. A novel time-resolved fluoroimmunoassay based on magnetic microspheres method for detecting antibodies against the phospholipase A2 receptor.[J]. Analytical methods : advancing methods and applications,2021.

练明建,卢榕,张加勤,等.血清抗PLA2R抗体检测对特发性膜 性肾病诊断效能的meta分析[J].临床检验杂志,2017,35(7):545- 549.

蒋真斌,蔡美顺,董葆,等.适合中国人的抗磷脂酶A2受体抗体临 界值的界定[J].中华肾脏病杂志,2020(5):379-384.

邱杰山,李青华,沈水娟,等.血清抗-PLA_2R抗体对特 发性膜性肾病诊断价值的meta分析[J].中国免疫学杂 志,2015,31(11):1515-1519.

薛痕,龚仲琴,常晓东,等.PLA2R、THSD7A与IgG亚型在特发性 膜性肾病中的诊断价值[J].临床肾脏病杂志,2020,20(1):6-11.

Rao Si Jie,Shen Qing,Wang Hong Mei,Tang Shi,Wang Xiang Yan. The association of anti-PLA2R with clinical manifestations and outcomes in idiopathic membranous nephropathy: a meta-analysis. [J]. International urology and nephrology,2020.

PLA2R Autoantibodies and Recurrent Membranous Nephrop- athy after Transplantation[J]. New England Journal of Medi- cine,2010,363(5).

Seitz-Polski Barbara et al. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.[J]. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, 29(12):2334-2342.

黄俊,李剑文,梁鸣,等.血清抗磷脂酶A_2受体抗体滴度预测特发 性膜性肾病的临床结局[J].广东医学,2017,38(9):1348-1353.

茹彦海,徐家云,赵富利.抗PLA2R抗体在特发性膜性肾病血栓 易感状态中的作用研究[J].实验与检验医学,2021,39(3):563- 566.

王佳,桑晓红,张菁菁.特发性膜性肾病患者血清抗M型磷脂酶 A-2受体抗体阳性率与肾间质损伤的关系[J].中华实用诊断与 治疗杂志,2021,35(3):247-250.

Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy[J]. J Am Soc Nephrol,2014,25(6):1357-1366.

Ruggenenti P, Debiec H, Ruggiero B, et al. Anti-phospholipase a2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy[J]. J Am Soc Nephrol, 2015,26(10):2545-2558.

李强,张蓓茹,何平,等.血清PLA2R抗体检测在特发性膜性肾病 临床




DOI: https://doi.org/10.12346/pmr.v4i3.6692

Refbacks

  • 当前没有refback。